BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25589479)

  • 1. Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.
    Rajaobelina K; Cougnard-Gregoire A; Delcourt C; Gin H; Barberger-Gateau P; Rigalleau V
    J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):841-6. PubMed ID: 25589479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant.
    Calviño J; Cigarran S; Gonzalez-Tabares L; Menendez N; Latorre J; Cillero S; Millan B; Cobelo C; Sanjurjo-Amado A; Quispe J; Garcia-Enriquez A; Carrero JJ
    PLoS One; 2018; 13(8):e0201118. PubMed ID: 30067789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study.
    van Waateringe RP; Slagter SN; van der Klauw MM; van Vliet-Ostaptchouk JV; Graaff R; Paterson AD; Lutgers HL; Wolffenbuttel BH
    Eur J Clin Invest; 2016 May; 46(5):481-90. PubMed ID: 27002914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes.
    Bentata R; Cougnard-Grégoire A; Delyfer MN; Delcourt C; Blanco L; Pupier E; Rougier MB; Rajaobelina K; Hugo M; Korobelnik JF; Rigalleau V
    J Diabetes Complications; 2017 Mar; 31(3):619-623. PubMed ID: 28063765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
    Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
    Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between dietary and skin advanced glycation end products: the Rotterdam Study.
    Chen J; Waqas K; Tan RC; Voortman T; Ikram MA; Nijsten TEC; de Groot LCPGM; Uitterlinden AG; Zillikens MC
    Am J Clin Nutr; 2020 Jul; 112(1):129-137. PubMed ID: 32453418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Skin Autofluorescence Levels With Kidney Function Decline in Patients With Peripheral Artery Disease.
    Schutte E; de Vos LC; Lutgers HL; Lambers Heerspink HJ; Wolffenbuttel BH; Vart P; Zeebregts CJ; Gansevoort RT; Lefrandt JD
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1709-14. PubMed ID: 27365407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study.
    van der Heyden JC; Birnie E; Mul D; Bovenberg S; Veeze HJ; Aanstoot HJ
    BMC Endocr Disord; 2016 Sep; 16(1):49. PubMed ID: 27613110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin autofluorescence of Advanced Glycation End-products and mortality in older adults: The roles of chronic kidney disease and diabetes.
    Majchrzak C; Cougnard-Gregoire A; Le-Goff M; Féart C; Delcourt C; Reydit M; Helmer C; Rigalleau V
    Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2526-2533. PubMed ID: 36064683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes.
    Rajaobelina K; Helmer C; Vélayoudom-Céphise FL; Nov S; Farges B; Pupier E; Blanco L; Hugo M; Gin H; Rigalleau V
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28719154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of skin autofluorescence as a surrogate of advanced glycation end products accumulation in children and adolescents with normal haemoglobin A1c values.
    Jankowska M; Bobeff K; Baranowska-Jaźwiecka A; Mianowska M; Lubnauer A; Michalak A; Młynarski W; Szadkowska A; Mianowska B
    Pediatr Endocrinol Diabetes Metab; 2020; 26(1):1-9. PubMed ID: 32418416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin autofluorescence and glycemic variability.
    Noordzij MJ; Lefrandt JD; Graaff R; Smit AJ
    Diabetes Technol Ther; 2010 Jul; 12(7):581-5. PubMed ID: 20597834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study.
    Birukov A; Cuadrat R; Polemiti E; Eichelmann F; Schulze MB
    Cardiovasc Diabetol; 2021 Jun; 20(1):110. PubMed ID: 34176469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue.
    Yue X; Hu H; Koetsier M; Graaff R; Han C
    Diabet Med; 2011 Jul; 28(7):818-23. PubMed ID: 21204956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus.
    Banser A; Naafs JC; Hoorweg-Nijman JJ; van de Garde EM; van der Vorst MM
    Pediatr Diabetes; 2016 Sep; 17(6):426-32. PubMed ID: 26332801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population.
    Isami F; West BJ; Nakajima S; Yamagishi SI
    J Int Med Res; 2018 Mar; 46(3):1043-1051. PubMed ID: 29322837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end products, measured as skin autofluorescence, during normal pregnancy and pregnancy complicated by diabetes mellitus.
    de Ranitz-Greven WL; Kaasenbrood L; Poucki WK; Hamerling J; Bos DC; Visser GH; Biesma DH; Beulens JW; de Valk HW
    Diabetes Technol Ther; 2012 Dec; 14(12):1134-9. PubMed ID: 23113747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study.
    Shardlow A; McIntyre NJ; Kolhe NV; Nellums LB; Fluck RJ; McIntyre CW; Taal MW
    PLoS Med; 2020 Jul; 17(7):e1003163. PubMed ID: 32658890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbid obesity leads to increased skin autofluorescence independent of metabolic syndrome components.
    Apaydın T; Yavuz DG
    Turk J Med Sci; 2022 Aug; 52(4):1085-1092. PubMed ID: 36326402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study.
    Alkhami F; Borderie G; Foussard N; Larroumet A; Blanco L; Barbet-Massin MA; Ferriere A; Ducos C; Mohammedi K; Fawaz S; Couffinhal T; Rigalleau V
    Diabetes Metab; 2024 Mar; 50(2):101524. PubMed ID: 38346471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.